Invisible graveyard from ceding AI

If a country (here: the U.S.) deliberately slows or restricts domestic AI development out of fear, medical and other life‑saving innovations may be produced abroad (e.g., China), priced and allocated in ways that leave many domestic patients untreated — an 'invisible graveyard' of preventable deaths. The argument reframes AI‑safety panic as a geopolitical and public‑health tradeoff, not just an abstract existential debate. — Recognizing this tradeoff changes how governments weigh precautionary AI measures against the real-world costs of ceding technological leadership in medicine and critical industries.